Corteva, Inc. $CTVA Shares Purchased by Legacy Financial Advisors Inc.

Legacy Financial Advisors Inc. lifted its stake in Corteva, Inc. (NYSE:CTVA) by 74.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,010 shares of the company’s stock after acquiring an additional 7,698 shares during the quarter. Legacy Financial Advisors Inc.’s holdings in Corteva were worth $1,207,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in CTVA. Perpetual Ltd lifted its holdings in shares of Corteva by 78,688.5% in the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after acquiring an additional 2,612,459 shares during the last quarter. Amundi lifted its holdings in shares of Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after acquiring an additional 1,899,248 shares during the last quarter. Squarepoint Ops LLC lifted its holdings in shares of Corteva by 423.6% in the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock worth $117,550,000 after acquiring an additional 1,406,199 shares during the last quarter. Man Group plc lifted its holdings in shares of Corteva by 16,474.3% in the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock worth $87,522,000 after acquiring an additional 1,286,317 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Corteva by 3.6% in the 3rd quarter. State Street Corp now owns 35,280,805 shares of the company’s stock worth $2,386,041,000 after acquiring an additional 1,230,074 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.15% of the company’s stock.

Corteva Trading Down 0.3%

Shares of NYSE:CTVA opened at $82.59 on Wednesday. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company’s 50 day moving average is $80.88 and its two-hundred day moving average is $73.03. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The company has a market cap of $55.24 billion, a PE ratio of 48.58, a P/E/G ratio of 2.68 and a beta of 0.59.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the firm posted $1.13 EPS. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.7 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Ratings Changes

A number of research firms have issued reports on CTVA. Rothschild & Co Redburn increased their target price on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. CICC Research increased their target price on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Wednesday, February 11th. Citigroup increased their target price on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Wells Fargo & Company increased their target price on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Finally, Wolfe Research increased their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $87.52.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.